Royal Bank of Canada’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
969
-7,571
| -89% | -$7.81K | ﹤0.01% | 6459 |
|
|
2025
Q1 | $9K | Sell |
8,540
-6,121
| -42% | -$6.45K | ﹤0.01% | 5794 |
|
|
2024
Q4 | $25K | Buy |
14,661
+8,720
| +147% | +$14.9K | ﹤0.01% | 5519 |
|
|
2024
Q3 | $15K | Buy |
5,941
+1,896
| +47% | +$4.79K | ﹤0.01% | 5723 |
|
|
2024
Q2 | $10K | Buy |
4,045
+3,943
| +3,866% | +$9.75K | ﹤0.01% | 5927 |
|
|
2024
Q1 | $0 | Sell |
102
-566
| -85% | – | ﹤0.01% | 6486 |
|
|
2023
Q4 | $2K | Buy |
668
+566
| +555% | +$1.7K | ﹤0.01% | 6234 |
|
|
2023
Q3 | $0 | Sell |
102
-194
| -66% | – | ﹤0.01% | 6516 |
|
|
2023
Q2 | $1K | Sell |
296
-88
| -23% | -$297 | ﹤0.01% | 6491 |
|
|
2023
Q1 | $2K | Buy |
384
+379
| +7,580% | +$1.97K | ﹤0.01% | 6353 |
|
|
2022
Q4 | $0 | Sell |
5
-46
| -90% | – | ﹤0.01% | 6685 |
|
|
2022
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 6641 |
|
|
2022
Q2 | – | Sell |
-1,739
| Closed | -$7K | – | 6845 |
|
|
2022
Q1 | $7K | Sell |
1,739
-631
| -27% | -$2.54K | ﹤0.01% | 6609 |
|
|
2021
Q4 | $16K | Buy |
2,370
+1,269
| +115% | +$8.57K | ﹤0.01% | 6346 |
|
|
2021
Q3 | $16K | Buy |
+1,101
| New | +$16K | ﹤0.01% | 6258 |
|